Last Update: Jan 21, 2026
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE-2)
ClinicalTrials.gov Identifier:
Novartis Reference Number:CLOU064J12302
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

Study Description

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS). The total duration of the study is 76 weeks and consists of: Screening (up to 4 weeks), Treatment Period 1 (16 weeks, double-blind treatment with remibrutinib (Dose A or Dose B) or placebo, Treatment Period 2 (52 weeks, treatment with remibrutinib (Dose A or Dose B) and Safety Follow-Up (treatment-free follow-up for 4 weeks).

Participants who prematurely discontinue study treatment (either during Treatment Period 1 or Treatment Period 2) are encouraged to remain in the study. Participants who do not wish to remain in the study will enter a 4-week Safety Follow-Up period.

Hidradenitis Suppurativa
Phase3
Recruiting
555
Mar 20, 2025
Mar 17, 2028
All
12 Years - 100 Years (Child, Adult, Older Adult)

Interventions

Drug

Placebo 1

Placebo matching to remibrutinib Dose A (oral)
Drug

Placebo 2

Placebo matching to remibrutinib Dose B (oral)
Drug

Remibrutinib Dose A

Remibrutinib Dose A (oral)
Drug

Remibrutinib Dose B

Remibrutinib Dose B (oral)

Eligibility Criteria

Key Inclusion Criteria:

1. Male and female participants ≥ 12 years of age at the time of signing of the informed consent.
2. Diagnosis of HS based on clinical history and physical examination for at least 6 months prior to the Baseline visit.
3. Participants with moderate to severe HS defined as:

* A total of at least 5 AN count (abscesses and/or inflammatory nodules) AND
* Inflammatory lesions should affect at least 2 distinct anatomic areas (e.g., left and right axillae)

Key Exclusion Criteria:

1. Presence of more than 20 fistulae/tunnels (both draining and non-draining) in total at baseline.
2. Any active skin disease or conditions that may interfere with the assessment of HS.
3. Previous exposure to remibrutinib or other BTK inhibitors.
4. Use of other investigational drugs within 5 half-lives of enrollment, or within 30 days (for small molecules) prior to randomization, or until the pharmacodynamic effect has returned to baseline (for biologics), whichever is longer.
5. Significant bleeding risk or coagulation disorders.
6. History of gastrointestinal bleeding.
7. Requirement for anti-platelet (except for acetylsalicylic acid up to 100 mg/d or clopidogrel up to 75 mg/d) or anti-coagulant medication.
8. History or current hepatic disease.
9. Evidence of clinically significant cardiovascular, neurological, psychiatric, pulmonary, renal, hepatic, endocrine, metabolic, hematological disorders, gastrointestinal disease or immunodeficiency that, in the Investigator's opinion, would compromise the safety of the participant, interfere with the interpretation of the study results or otherwise preclude participation or protocol adherence of the participant.
10. History of hypersensitivity to any of the study drug constituents.
11. Known or suspected infectious disease that is active, chronic or recurrent which precludes the participant from participating in the trial as per investigator's assessment. These infectious diseases include and are not limited to opportunistic infections (e.g., tuberculosis, atypical mycobacterioses, listeriosis or aspergillosis) and/or known or suspected Human Immunodeficiency Virus (HIV) infection. Should it be required by local regulations and/or considered appropriate by the investigator, an HIV test can be performed to confirm eligibility.
12. History of live attenuated vaccine administration within 6 weeks prior to randomization or requirement to receive these vaccinations at any time while on study treatment.
13. Major surgery within 8 weeks prior to screening or planned surgery for the duration of the study.

Other protocol-defined inclusion/exclusion criteria may apply.

Novartis Investigative Site

Recruiting

Caba,C1205aao,Argentina

Novartis Investigative Site

Recruiting

CABA,C1012aay,Argentina

Novartis Investigative Site

Recruiting

Córdoba,B5000,Argentina

Novartis Investigative Site

Recruiting

Berazategui,Buenos Aires,B1837avt,Argentina

Novartis Investigative Site

Recruiting

Linz,4020,Austria

Novartis Investigative Site

Recruiting

Liège,4000,Belgium

Novartis Investigative Site

Recruiting

Brussels,Brussels Capital,1070,Belgium

Novartis Investigative Site

Recruiting

Woluwe-Saint-Lambert,Brussels Capital,B 1200,Belgium

Novartis Investigative Site

Recruiting

Leuven,Vlaams Brabant,3000,Belgium

Novartis Investigative Site

Recruiting

London,Ontario,N6h 5l5,Canada

Novartis Investigative Site

Recruiting

Montreal,Quebec,H1y 3l1,Canada

Novartis Investigative Site

Recruiting

Sherbrooke,Quebec,J1g 1x9,Canada

Novartis Investigative Site

Recruiting

Québec,Quebec,G1v 4t3,Canada

Novartis Investigative Site

Recruiting

Bogota,Cundinamarca,110110,Colombia

Novartis Investigative Site

Recruiting

Medellín,050012,Colombia

Novartis Investigative Site

Recruiting

Medellín,Antioquia,050010,Colombia

Novartis Investigative Site

Recruiting

Bogota,Cundinamarca,111411,Colombia

Novartis Investigative Site

Recruiting

Plzen Bolevec,32300,Czechia

Novartis Investigative Site

Recruiting

Prague,100 34,Czechia

Novartis Investigative Site

Recruiting

Prague,128 08,Czechia

Novartis Investigative Site

Recruiting

Prague,150 06,Czechia

Novartis Investigative Site

Recruiting

Karlovy Vary,360 01,Czechia

Novartis Investigative Site

Recruiting

Prague,180 81,Czechia

Novartis Investigative Site

Recruiting

Prague,150 00,Czechia

Novartis Investigative Site

Recruiting

Brest,29609,France

Novartis Investigative Site

Recruiting

La Rochelle,17019,France

Novartis Investigative Site

Recruiting

Lyon,69003,France

Novartis Investigative Site

Recruiting

Nice,06000,France

Novartis Investigative Site

Recruiting

Reims,51100,France

Novartis Investigative Site

Recruiting

Rouen,76031,France

Novartis Investigative Site

Recruiting

Toulouse,31400,France

Novartis Investigative Site

Recruiting

Bad Bentheim,48455,Germany

Novartis Investigative Site

Recruiting

Essen,45147,Germany

Novartis Investigative Site

Recruiting

Hamburg,20246,Germany

Novartis Investigative Site

Recruiting

Minden,32429,Germany

Novartis Investigative Site

Recruiting

Merzig,Saarland,66663,Germany

Novartis Investigative Site

Recruiting

Dortmund,44137,Germany

Novartis Investigative Site

Recruiting

Leipzig,Saxony,04103,Germany

Novartis Investigative Site

Recruiting

Dessau,06847,Germany

Novartis Investigative Site

Recruiting

Lübeck,23538,Germany

Novartis Investigative Site

Recruiting

München,80377,Germany

Novartis Investigative Site

Recruiting

Tübingen,72076,Germany

Novartis Investigative Site

Recruiting

Freiburg im Breisgau,Baden-Wurttemberg,79106,Germany

Novartis Investigative Site

Recruiting

Würzburg,Bavaria,97080,Germany

Novartis Investigative Site

Recruiting

Düsseldorf,North Rhine-Westphalia,40225,Germany

Novartis Investigative Site

Recruiting

Berlin,13595,Germany

Novartis Investigative Site

Recruiting

Frankfurt am Main,Hesse,60590,Germany

Novartis Investigative Site

Recruiting

Athens,161 21,Greece

Novartis Investigative Site

Recruiting

Chaïdári,124 62,Greece

Novartis Investigative Site

Recruiting

Thessaloniki,564 03,Greece

Novartis Investigative Site

Recruiting

Budapest,1036,Hungary

Novartis Investigative Site

Recruiting

Budapest,H-1083,Hungary

Novartis Investigative Site

Recruiting

Kecskemét,6001,Hungary

Novartis Investigative Site

Recruiting

Debrecen,Hajdu Bihar Megye,4032,Hungary

Novartis Investigative Site

Recruiting

Pécs,Baranya,7623,Hungary

Novartis Investigative Site

Recruiting

Debrecen,Hajdú-Bihar,4031,Hungary

Novartis Investigative Site

Recruiting

Szeged,6725,Hungary

Novartis Investigative Site

Recruiting

Ipoh,Perak,30450,Malaysia

Novartis Investigative Site

Recruiting

Kota Kinabalu,Sabah,88586,Malaysia

Novartis Investigative Site

Recruiting

Wilayah Persekutuan,62502,Malaysia

Novartis Investigative Site

Recruiting

Johor Bahru,80100,Malaysia

Novartis Investigative Site

Recruiting

Selangor Darul Ehsan,68100,Malaysia

Novartis Investigative Site

Recruiting

Kuala Lumpur,Kuala Lumpur,50586,Malaysia

Novartis Investigative Site

Recruiting

Durango,34000,Mexico

Novartis Investigative Site

Recruiting

Warsaw,02-507,Poland

Novartis Investigative Site

Recruiting

Warsaw,02-962,Poland

Novartis Investigative Site

Recruiting

Warsaw,Masovian Voivodeship,02-953,Poland

Alma Cruz-Santana Private Practice

Recruiting

Carolina,00985,Puerto Rico

Alma Cruz
Veronica Duque Osorno

Novartis Investigative Site

Recruiting

Bucharest,District 2,020125,Romania

Novartis Investigative Site

Recruiting

Bucharest,District 2,020762,Romania

Novartis Investigative Site

Recruiting

Bucharest,010825,Romania

Novartis Investigative Site

Recruiting

Timișoara,300188,Romania

Novartis Investigative Site

Recruiting

Pontevedra,36003,Spain

Novartis Investigative Site

Recruiting

Madrid,28041,Spain

Novartis Investigative Site

Recruiting

Granollers,08402,Spain

Novartis Investigative Site

Recruiting

Madrid,28006,Spain

Novartis Investigative Site

Recruiting

Granada,Andalusia,18014,Spain

Novartis Investigative Site

Recruiting

Barcelona,08041,Spain

Novartis Investigative Site

Recruiting

Valencia,46026,Spain

Novartis Investigative Site

Recruiting

Palma,Balearic Islands,07120,Spain

Novartis Investigative Site

Recruiting

Las Palmas GC,35010,Spain

Novartis Investigative Site

Recruiting

Seville,41009,Spain

Novartis Investigative Site

Recruiting

Izmir,Balcova,35340,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Ankara,Bilkent-Cankaya,06800,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Izmir,Buca,35390,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Aydin,Efeler,09100,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Ankara,Sihhiye-Altindag,06230,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Ankara,Yenimahalle,06500,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Mersin,Yenisehir,33110,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Izmir,35100,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Denizli,Kinikli,20070,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Kecioren Ankara,06010,Turkey (Türkiye)

Novartis Investigative Site

Recruiting

Cardiff,Cf14 4xw,United Kingdom

Novartis Investigative Site

Recruiting

London,Se5 9rs,United Kingdom

Novartis Investigative Site

Recruiting

Leeds,West Yorkshire,Ls7 4sa,United Kingdom

Novartis Investigative Site

Recruiting

London,E1 2at,United Kingdom

Novartis Investigative Site

Recruiting

London,Se1 9rt,United Kingdom

Novartis Investigative Site

Recruiting

Southampton,So16 6yd,United Kingdom

Austin Inst for Clinical Research

Recruiting

Pflugerville,Texas,78660,United States

Alivia Hernandez
Edward Lain

Total Skin and Beauty Dermatology Center PC

Recruiting

Birmingham,Alabama,35205,United States

Brittany Powell
Rajini Murthy

Ctr for Dermatology Clinical Res

Recruiting

Fremont,California,95438,United States

Evguenia Vals
Sunil Dhawan

Endeavor Health

Recruiting

Glenview,Illinois,60077,United States

Megan Calderon
Shannon Ewing

Southern IN Clinical Trials

Recruiting

New Albany,Indiana,47150,United States

Megan Landis
Skyler Carl

Skin Specialists PC

Recruiting

Omaha,Nebraska,68144,United States

Joel Schlessinger
Kayleigh Koziol

Accurate Clinical Research

Recruiting

Humble,Texas,77346,United States

Chinelo Fangtang
Valerie Blanco

Care Access Alexandria

Recruiting

Arlington,Virginia,22206,United States

David Bray
Ernest Evans

Complexions Dermatology

Recruiting

Danville,Virginia,24541,United States

Janaya Patron
Keith Robinson

Ctr Dermatology and Plastic Surgery

Recruiting

Scottsdale,Arizona,85260,United States

Kenneth Steil
Lindsey Arcuri

USC Keck School of Medicine

Recruiting

Los Angeles,California,90033,United States

Katrina Lee
Kenan Kherallah

Floridian Research Institute

Recruiting

Miami,Florida,33179,United States

Gretel Trullenque
Yusmara Villa

Metro Boston Clinical Partners

Recruiting

Brighton,Massachusetts,02135,United States

Mark Amster
Stella Schandorf

Clinical Research Inst of MI

Recruiting

Chesterfield,Michigan,48047,United States

Joachina Jenuwine
Natalia Filipof

North Shore University Hospital

Recruiting

New Hyde Park,New York,11040,United States

Alicia Premdas
Amit Garg

Cameron Dermatology

Recruiting

New York,New York,10023,United States

Grace Ulerio
Michael Cameron

Ohio State University

Recruiting

Columbus,Ohio,43210,United States

Elizabeth Begle
Jessica Kaffenberger

Wright State University

Recruiting

Fairborn,Ohio,45324,United States

Craig Rohan
Jessica Hong

Apex Clinical Research Center LLC

Recruiting

Mayfield Heights,Ohio,44124,United States

Brooke Glivar
Jorge Garcia-Zuazaga

Clinical Research Ctr of Carolinas

Recruiting

Charleston,South Carolina,29407,United States

Gina Gregory
Todd Schlesinger

Center for Clinical Studies-Lee

Recruiting

Webster,Texas,77598,United States

Karina Gonzalez
Patricia C Lee

Forefront Dermatology

Recruiting

Vienna,Virginia,22182,United States

Gianna Riley
Naiem Issa

CTT Research

Recruiting

Gilbert,Arizona,85234,United States

Lori Kuuipo Eiko Ramirez
Ranvitha Davalagar

MedDerm Associates

Recruiting

San Diego,California,92103,United States

Kristian Cadag
Michelle Pelle

Driven Research

Recruiting

Coral Gables,Florida,33134,United States

Haymara Gonzalez
Javier Alonso Llamazares

University Of South Florida

Recruiting

Tampa,Florida,33612,United States

Ann Lin
Lucy Lam

Emory School of Med Dermatology

Recruiting

Atlanta,Georgia,30303,United States

Julie Bonds
Lauren Orenstein

Dundee Dermatology

Recruiting

West Dundee,Illinois,60118,United States

JoAnn Hawkinson
Paul Getz

Optima Research Boardman

Recruiting

Boardman,Ohio,44512,United States

Patrick Shannon
Robert Mackovick

Sarasota Arthritis Res Ctr

Recruiting

Sarasota,Florida,34239,United States

Jesse Boodoo
Nancy Alvarado

Northwestern University

Recruiting

Chicago,Illinois,60611,United States

Itzel Lara
Kelsey Flood

Beth Israel Deaconess Med Center

Recruiting

Boston,Massachusetts,02215,United States

Alexa B Kimball
Nazrin Ashina

Vivida Dermatology

Recruiting

Las Vegas,Nevada,89119,United States

Tracey Jablonka
Victoria Farley

Goodlettsville Dermatology Research

Recruiting

Goodlettsville,Tennessee,37072-2301,United States

David Laneve
Keith H Loven

Atlanta Biomedical Clin Res LLC

Recruiting

Atlanta,Georgia,30331,United States

Leah Morse
Tunisia Cornelius

Deluxe Dermatology

Recruiting

St Louis,Missouri,63117,United States

Duane Dilworth
Stephanie Kirkpatrick

Worldwide Contacts

If the location of your choosing does not feature any contact detail, please reach out using the information below.

Novartis Pharmaceuticals

Novartis Pharmaceuticals